Orbital Rhabdomyosarcoma with a good life prognosis after surgical treatment in a 14-year-old patient
- 36 Downloads
The orbital rhabdomyosarcoma is one of the most frequent malignant orbital tumours in children. At this age, the common histological types are the embryonal and alveolar type. The onset is mainly under the age of 16. Without a recent and correct treatment it can give metastasis in lung and bone. The hereby paper presents one clinical case of a teenager presented at the ophthalmological consultation for a small tumor located in the superomedial part of the orbit. Computed tomography (CT) and magnetic resonance imaging (MRI) supported the diagnosis revealing the location and extension of the tumor. During the surgery, we discovered two small tumors and the histological examination revealed an embryonal type of orbital rhabdomyosarcoma. After the surgery, the patient followed an oncological treatment consisting of chemotherapy and local radiotherapy. The prognosis for life was favorable, linked with the recent diagnosis and treatment, the histological type and the good response at the oncological treatment.
KeywordsOrbital rhabdomyosarcoma Local radiotherapy Chemotherapy
Unable to display preview. Download preview PDF.
- Rootman J, Neoplasia, Diseases of the orbit: a multidisciplinary approach, Lippincott Williams and Wilkins, Philadelphia, 2003, 54, 262–268Google Scholar
- Koopman JH, van der Heiden-van der Loo M, van Dijk MR, Bijlsma WR, Incidence of primary malignant orbital tumours in The Netherlands Eye (Lond), 2011, 25, 461–465Google Scholar
- Kanski JJ, Clinical Ophtalmology, 4th ed., Butterworth Heinemann, Oxford, 1999, 581–582.Google Scholar
- Sanz-Marco E, España E, Alamar A, Pérez-Rojas J, López-Prats MJ, Díaz-Llopis M. Orbital alveolar rhabdomyosarcoma masked by ethmoid sinusitis in a 25-year-old, Arch Soc Esp Oftalmol., 2012, S0365-6691(12)00538-2. doi: 10.1016/j. oftal.2012.10.012Google Scholar
- Raney RB, Maurer HM, Anderson JR, Andrassy RJ, Donaldson SS, Qualman SJ et al., The Intergroup Rhabdomyosarcoma Study Group (IRSG): major lessons from the IRS-I through IRS-IV studies as background for the current IRS-V treatment protocols, Sarcoma, 2001, 5, 9–15PubMedCentralPubMedCrossRefGoogle Scholar
- Rosenberg AR, Anderson JR, Lyden E, Rodeberg DA, Wolden SL, Kao SC, Parham DM, Arndt C, Hawkins DS. Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: A report from the Children’s Oncology Group, Eur J Cancer, 2013, S0959-8049(13)01027-7. doi: 10.1016/j.ejca.2013.11.031Google Scholar